This is to inform you that the Board of Directors of the Company have approved to incorporate a limited liability company in Poland as a wholly-owned subsidiary. Details required vide SEBI circular dated 13-July-2023 are given in the annexure.
Announcement under Regulation 30 (LODR)-Acquisition
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Feb 07 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Sudarshan Pharma Industries Ltd Press Release Feb 05 2025
- Shareholder Meeting / Postal Ballot-Outcome of EGM
- Sudarshan Pharma Industries Ltd Press Release Feb 04 2025
Later from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
- Sudarshan Pharma Industries Ltd Press Release Feb 26 2025
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Sudarshan Pharma Industries Ltd Press Release Mar 04 2025
- Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries